Doheny Asset Management’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-40,820
Closed -$367K 67
2025
Q3
$367K Sell
40,820
-23,970
-37% -$210K 0.23% 51
2025
Q2
$842K Sell
64,790
-6,595
-9% -$99.2K 0.59% 40
2025
Q1
$1.8M Buy
71,385
+32,085
+82% +$953K 1.41% 23
2024
Q4
$1.35M Sell
39,300
-26,210
-40% -$1.18M 1.01% 28
2024
Q3
$3.24M Buy
65,510
+51,020
+352% +$2.61M 2.21% 14
2024
Q2
$872K Buy
14,490
+4,940
+52% +$282K 0.62% 40
2024
Q1
$493K Buy
+9,550
New +$469K 0.41% 51

Other funds holding RXST

Doheny Asset Management's RXST Position: Q4 2025 in Review

Doheny Asset Management sold out of RxSight (RXST) in Q4 2025, closing a stake of 40,820 shares — an estimated $367K sold.

Doheny Asset Management first reported a position in RXST in Q1 2024 and held it in 7 quarters. The position peaked at $3.24M in Q3 2024. 163 funds tracked by Wall St. Rank hold RXST as of Q4 2025.

  • Doheny Asset Management reported no remaining RxSight position as of Q4 2025 after selling out during the quarter.
  • Doheny Asset Management sold 40,820 RxSight shares in Q4 2025, an estimated $367K.
  • Doheny Asset Management first reported a position in RxSight in Q1 2024 and held it in 7 quarters.
  • Doheny Asset Management's RxSight position peaked at $3.24M in Q3 2024.
  • 163 funds tracked by Wall St. Rank held RxSight as of Q4 2025.

Based on Doheny Asset Management's 13F filing for Q4 2025, filed 11 Feb 2026.